SGK3 Antibody [D18P23]

Catalog No.: F6719

Application: Reactivity: Human, Mouse, Rat, Monkey

Lane 1: MCF7, Lane 2: COS-7, Lane 3: COLO 205

当該製品は品切れ状态で、ごメールアドレスを教えていただければ、在庫があると、メールで顧客様に伝えます。

代表番号: 045-509-1970|電子メール：sales@selleck.co.jp

使用情報

Dilution
WB1:1000 IP1:50

Application
WB, IP

Source
Rabbit Monoclonal Antibody

Reactivity
Human, Mouse, Rat, Monkey

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW
61 kDa

Datasheet & SDS

生物学的記述

Specificity
SGK3 Antibody [D18P23] detects endogenous levels of total SGK3 protein.

Clone
D18P23

Synonym(s)
Serine/threonine-protein kinase Sgk3; Cytokine-independent survival kinase; Serum/glucocorticoid-regulated kinase 3; Serum/glucocorticoid-regulated kinase-like; SGK3; CISK; SGKL

Background
SGK3 (serum- and glucocorticoid-inducible kinase 3), a member of the SGK subfamily within the AGC kinase group and closely related to Akt, serves as an alternative effector in PI3K signaling, particularly in contexts where canonical Akt activation is compromised. It possesses a phox homology (PX) domain that uniquely binds phosphatidylinositol-3-phosphate (PI3P) on endosomes, alongside a kinase domain activated by sequential phosphorylation. Growth factors like IGF1 trigger SGK3 activation through dual Class 1 and Class 3 PI3K pathways: Class 1 PI3K generates PI(3,4,5)P3 that SHIP2 converts to PI3P for PX-domain recruitment, while mTORC2 phosphorylates the hydrophobic motif at Ser422 to prime T-loop Thr320 phosphorylation by PDK1, inducing a conformational shift that unlocks catalytic activity; concurrently, Class 3 PI3K (hVps34) directly produces PI3P via the UV-RAG complex, ensuring robust endosomal localization even when Class 1 PI3K is inhibited. Activated SGK3 then phosphorylates downstream targets like NDRG1 to promote its FBXW7-mediated degradation, enhancing cell migration and anchorage-independent growth, while sustaining glycogen synthase kinase-3 inhibition and FOXO3a nuclear exclusion to favor survival and proliferation. This pathway substitutes for Akt in PIK3CA-mutant breast and liver cancers, driving tumorigenesis through INPP4B-dependent PI3P accumulation, and physiologically regulates neuronal ion transport, renal sodium reabsorption, and metabolic adaptation to stress. Upregulation confers therapy resistance in PTEN-low cancers, while knockout impairs folliculogenesis and glucose homeostasis.

Background

SGK3 (serum- and glucocorticoid-inducible kinase 3), a member of the SGK subfamily within the AGC kinase group and closely related to Akt, serves as an alternative effector in PI3K signaling, particularly in contexts where canonical Akt activation is compromised. It possesses a phox homology (PX) domain that uniquely binds phosphatidylinositol-3-phosphate (PI3P) on endosomes, alongside a kinase domain activated by sequential phosphorylation. Growth factors like IGF1 trigger SGK3 activation through dual Class 1 and Class 3 PI3K pathways: Class 1 PI3K generates PI(3,4,5)P3 that SHIP2 converts to PI3P for PX-domain recruitment, while mTORC2 phosphorylates the hydrophobic motif at Ser422 to prime T-loop Thr320 phosphorylation by PDK1, inducing a conformational shift that unlocks catalytic activity; concurrently, Class 3 PI3K (hVps34) directly produces PI3P via the UV-RAG complex, ensuring robust endosomal localization even when Class 1 PI3K is inhibited. Activated SGK3 then phosphorylates downstream targets like NDRG1 to promote its FBXW7-mediated degradation, enhancing cell migration and anchorage-independent growth, while sustaining glycogen synthase kinase-3 inhibition and FOXO3a nuclear exclusion to favor survival and proliferation. This pathway substitutes for Akt in PIK3CA-mutant breast and liver cancers, driving tumorigenesis through INPP4B-dependent PI3P accumulation, and physiologically regulates neuronal ion transport, renal sodium reabsorption, and metabolic adaptation to stress. Upregulation confers therapy resistance in PTEN-low cancers, while knockout impairs folliculogenesis and glucose homeostasis.

References
[1] Gasser JA, et al. Mol Cell. 2014 Nov 20;56(4):595-607. [2] Malik N, et al. Biochem J. 2018 Jan 2;475(1):117-135.

PVDFメンブレン孔径参考表

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須

* 大学・企業名 大学・企業名を記入してください

* 名前 名前を記入してください

* 電子メール 電子メール・アドレスを記入してください 有効なメールアドレスを入力してください

電話番号

* 内容 お問い合わせ内容をご入力ください

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%